Trials / Withdrawn
WithdrawnNCT04343183
Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Ochsner Health System · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients who meet inclusion criteria will be randomized into treatment vs control group. Treatment groups will undergo Hyperbaric Oxygen Therapy (HBOT) and compared to the control group.
Detailed description
After enrollment, patients will be randomized into treatment vs control group. Both populations will receive the same inpatient medical treatment. All patients in the treatment group will undergo hyperbaric oxygen therapy under the same treatment protocol. After completion of the treatment protocol, specific study endpoints will be compared between the treatment and control groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hyperbaric Oxygen Therapy | Hyperbaric Oxygen Therapy delivered at a specific uniformed pressure and duration. |
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2020-06-01
- Completion
- 2020-06-01
- First posted
- 2020-04-13
- Last updated
- 2023-04-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04343183. Inclusion in this directory is not an endorsement.